Mayne Pharma reported $1.47B in Assets for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Ansell ANN:AU $ 2.58B 155.6M
Cochlear COH:AU $ 2.43B 5.9M
CSL CSL:AU $ 23.44B 5.28B
Ecofibre Ltd EOF:AU 141.92M 171K
Healius Ltd HLS:AU $ 3.92B 138M
Integral Diagnostics Ltd IDX:AU 716.6M 61.7M
Nanosonics Ltd NAN:AU $ 171.23M 8.93M
Next Science Ltd NXS:AU 13.72M 5.44M
Polynovo Ltd PNV:AU 38.34M 2.03M
Probiotec Ltd PBP:AU 219.03M 11.84M
Ramsay Health Care RHC:AU $ 17.15B 2.17B
ResMed RMD:AU $ 4.91B 170.52M
Sigma Healthcare Ltd SIG:AU 1.25B 31.31M
Sonic Healthcare SHL:AU $ 12.46B 703.2M
Telix Pharmaceuticals Ltd TLX:AU 109.81M 19.03M